Menu
GeneBe

UQCRQ

ubiquinol-cytochrome c reductase complex III subunit VII, the group of Mitochondrial complex III: ubiquinol-cytochrome c reductase complex subunits

Basic information

Region (hg38): 5:132866629-132868847

Links

ENSG00000164405NCBI:27089OMIM:612080HGNC:29594Uniprot:O14949AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • mitochondrial complex III deficiency nuclear type 4 (Strong), mode of inheritance: AR
  • mitochondrial complex III deficiency (Supportive), mode of inheritance: AR
  • mitochondrial complex III deficiency nuclear type 4 (Limited), mode of inheritance: Unknown
  • Leigh syndrome (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Mitochondrial complex III deficiency, nuclear type 4ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic18439546
Individuals may suffer acute episodes of metabolic crisis; Treatment with "Mitochondrial cocktail" type therapy may be beneficial

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the UQCRQ gene.

  • Mitochondrial complex III deficiency nuclear type 4 (1 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the UQCRQ gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
6
missense
1
clinvar
14
clinvar
15
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
35
clinvar
7
clinvar
8
clinvar
50
Total 1 0 50 13 8

Highest pathogenic variant AF is 0.00000656

Variants in UQCRQ

This is a list of pathogenic ClinVar variants found in the UQCRQ region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-132866668-TG-T Mitochondrial complex III deficiency nuclear type 1 Uncertain significance (Jun 14, 2016)350837
5-132866678-G-C not specified Likely benign (Mar 31, 2017)508414
5-132866683-G-C Mitochondrial complex III deficiency nuclear type 4 Uncertain significance (Jan 13, 2018)350838
5-132866685-C-T Mitochondrial complex III deficiency nuclear type 4 Conflicting classifications of pathogenicity (Jan 12, 2018)904277
5-132866707-T-C Benign (Mar 03, 2015)1183892
5-132866719-C-G Benign (Jun 23, 2018)1225029
5-132866847-C-T Likely benign (Jul 15, 2018)1318354
5-132866851-C-T not specified Likely benign (Jul 25, 2017)510745
5-132866891-G-A Mitochondrial complex III deficiency nuclear type 4 • UQCRQ-related disorder Conflicting classifications of pathogenicity (Dec 05, 2023)215349
5-132866903-C-A Mitochondrial complex III deficiency nuclear type 4 Uncertain significance (Jan 27, 2018)1033694
5-132866926-C-T Mitochondrial complex III deficiency nuclear type 4 Conflicting classifications of pathogenicity (Dec 13, 2023)350839
5-132866941-A-G Likely benign (Aug 04, 2023)2416445
5-132866962-T-C Likely benign (Dec 11, 2023)737693
5-132866965-G-T UQCRQ-related disorder Likely benign (Feb 23, 2021)3031656
5-132866971-C-G not specified Likely benign (Jul 07, 2018)513958
5-132866971-C-T Mitochondrial complex III deficiency nuclear type 4 Conflicting classifications of pathogenicity (Jun 03, 2023)669826
5-132866976-C-T not specified Conflicting classifications of pathogenicity (Jul 05, 2022)215350
5-132866982-G-T not specified Uncertain significance (Mar 16, 2022)2392753
5-132866989-C-G not specified • Mitochondrial complex III deficiency nuclear type 4 Conflicting classifications of pathogenicity (Dec 11, 2023)137891
5-132866991-A-C Uncertain significance (Oct 13, 2023)1958085
5-132866991-A-G not specified Uncertain significance (May 28, 2024)2402585
5-132866994-T-A not specified Uncertain significance (Jun 24, 2022)2296737
5-132866997-T-G Uncertain significance (Apr 14, 2022)2420693
5-132867015-C-T Mitochondrial complex III deficiency nuclear type 4 Pathogenic (Jun 16, 2015)729
5-132867023-C-T not specified Uncertain significance (Jan 02, 2024)3186890

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
UQCRQprotein_codingprotein_codingENST00000378670 21472
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.04830.698125736041257400.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4164250.30.8350.00000230534
Missense in Polyphen1715.7371.0803176
Synonymous-0.4292219.61.129.33e-7159
Loss of Function0.63223.220.6201.45e-733

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002640.0000264
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: This is a component of the ubiquinol-cytochrome c reductase complex (complex III or cytochrome b-c1 complex), which is part of the mitochondrial respiratory chain. This subunit, together with cytochrome b, binds to ubiquinone.;
Disease
DISEASE: Mitochondrial complex III deficiency, nuclear 4 (MC3DN4) [MIM:615159]: A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance. {ECO:0000269|PubMed:18439546}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Cardiac muscle contraction - Homo sapiens (human);Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human);Alzheimer,s disease - Homo sapiens (human);Huntington,s disease - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Parkinson,s disease - Homo sapiens (human);Electron Transport Chain;Respiratory electron transport;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. (Consensus)

Recessive Scores

pRec
0.0550

Intolerance Scores

loftool
0.371
rvis_EVS
0.08
rvis_percentile_EVS
59.76

Haploinsufficiency Scores

pHI
0.0176
hipred
Y
hipred_score
0.587
ghis
0.449

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.801

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Uqcrq
Phenotype

Gene ontology

Biological process
mitochondrial electron transport, ubiquinol to cytochrome c;subthalamus development;pons development;cerebellar Purkinje cell layer development;hippocampus development;thalamus development;hypothalamus development;pyramidal neuron development;midbrain development
Cellular component
mitochondrion;mitochondrial inner membrane;mitochondrial respiratory chain complex III
Molecular function
ubiquinol-cytochrome-c reductase activity